期刊文献+

疏血通联合低分子肝素钠治疗深静脉血栓的疗效观察 被引量:2

Efficacy of Shuxuetong Injection Combined Low Molecular Weight Heparin in Treating Deep Vein Thrombosis
下载PDF
导出
摘要 目的探讨疏血通联合低分子肝素钠治疗下肢深静脉血栓症的临床疗效和安全性。方法将70例下肢深静脉血栓症患者随机分为试验组和对照组,每组各35例。对照组予低分子肝素纳5000U皮下注射,每12小时1次。试验组在此基础上加用疏血通注射液6mL+生理盐水250mL静脉点滴,每天1次,10d为一疗程。结果试验组总有效率94.3%,对照组为68.6%,两组比较差异有统计学意义(P<0.05),两组均未出现严重不良反应。结论疏血通联合低分子肝素钠治疗下肢静脉血栓症疗效显著,安全性好。 Objective To study the clinical curative effect and safety of lower extremity deep venous thrombosis treated by both Shuxuetong injection and Low molecular weight heparin.Methods 70 cases of deep vein thrombosis were randomLy divided into test group and control group,35 patients in each group.Control group was received subcutaneous injection of low molecular weight heparin sodium 5000U,every 12 hours.Based on this powerful horse trials plus Shuxuetong 6mL + saline injection 250mL intravenously,once daily,10 days for treatment.Results The total effective rate was94.2% in test group,68.6% in control group,significant difference between the two groups(P0.05﹚,two groups were no severe adverse reactions.Conclusion The therapeutic effect of treatment of Lower extremity venous thrombosis by both Shuxuetong injection and Low molecular weight heparin are superior and remarkable safety.
出处 《中国医药科学》 2011年第9期108-109,共2页 China Medicine And Pharmacy
关键词 疏血通注射液 低分子肝素钠 深静脉血栓 Shuxuetong injection Low molecular weight heparin Deep vein thrombosis
  • 相关文献

参考文献3

二级参考文献27

  • 1刘刚.新的抗凝药物─—水蛭肽的研究进展[J].国外医学(药学分册),1995,22(3):133-138. 被引量:20
  • 2顾兆芝.直接抗凝血酶药物——水蛭肽的临床应用[J].中国海洋药物,1996,15(3):52-54. 被引量:3
  • 3The NINDS rt—PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J],New Engl J Med,1995,333(24):1581—1587.
  • 4David SG. Richard AP, Thomas C, et al. Intravenous ancrod for treatment of acute ischemic stroke: The STAT study: a randomized controlled trial[J]. JAMA, 2002,283 ( 18 ) : 2395 - 2403.
  • 5Ryu GH, Park S, Han DK, et al. Antithrombogenicity of lumbrokinase- immobilized polyurethane [J]. J Biomed Mater Res ,1994,28(9) :1069-1077.
  • 6范乔 赫荣乔 吴岑.粉正蚓纤溶酶Ⅲ—1在肠内吸收的部分性质[J].Biochim Biophys Acta,2001,1526(9):286-286.
  • 7The NINDS rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].New Engl J Med,1995,333(24):1581-1587.
  • 8David SG.Richard AP,Thomas C,et al.Intravenous ancrod for treatment of acute ischemic stroke:The STAT study:a randomized controlled trial[J].JAMA,2002,283(18):2395-2403.
  • 9Ryu GH,Park S,Han DK,et al.Antithrombogenicity of lumbrokinase- immobilized polyurethane[J].J Biomed Mater Res,1994,28(9):1069-1077.
  • 10MaoS.J.T.,YatesM.T.,OwenT.J.&KrstenanskyJ.L.Biochemistry,1988(27):8170—8173

共引文献58

同被引文献35

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部